In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Update Commission Regulation regarding monacolins from red yeast rice

Update Commission Regulation regarding monacolins from red yeast rice

by In2Pharma | Jul 5, 2022 | News

Europe The Commission Regulation (EU) 2022/860 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards monacolins from red yeast rice has been published on 2nd June 2022. This Regulation entered into force on 22nd...

Recent Posts

  • Update Belgian FAQ on nutrition and health claims
  • Simplification of disclaimers for promotional materials
  • REACH Microplastics Restriction: What You Need to Know – and Do – Today!
  • “Successive GMP certificate” applications
  • New contact form for questions on variations and renewals from 1 June 2025

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België